Showing results (141-150 of 173) with videos related to
Sort By:
Pageof 18
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 6, 2025
Exploratory study on plasma Acylglycerol and Acylethanolamide dysregulation in substance use and attention-deficit/hyperactivity disorder: Implications for novel biomarkers in dual diagnosisMaría Flores-López, Jesús Herrera-Imbroda, Nerea Requena-Ocaña, et al.Neuropharmacology|May 8, 2025
"Maladaptive stress-coping behavior in CX<sub>3</sub>CR1-deficient mice: Impact of adolescent stress and alcohol exposure on neuroimmune responses and inflammation"Dina Medina-Vera, Laura Martín-Chaves, Laura Sánchez-Marín, et al.The European Journal of Neuroscience|October 5, 2012
Diet-dependent modulation of hippocampal expression of endocannabinoid signaling-related proteins in cannabinoid antagonist-treated obese ratsPatricia Rivera, María Jesús Luque-Rojas, Antoni Pastor, et al.Toxics|May 27, 2026
Plasma Concentrations of Endotoxin Lipopolysaccharide and High-Mobility Group Box 1 Protein Are Consistent Sex-Specific Biomarkers of Alcohol Abstinence Associated with Alcohol Use DisorderIsaac Hurtado-Guerrero, Nuria García-Marchena, Jaime Martín-Martín, et al.American Journal of Physiology. Endocrinology and Metabolism|February 3, 2012
Adiponectin promoter activator NP-1 reduces body weight and hepatic steatosis in high-fat diet-fed animalsAntonia Serrano, Francisco J Pavón, Juan Suarez, et al.Plos One|September 24, 2016
Effects of Adolescent Intermittent Alcohol Exposure on the Expression of Endocannabinoid Signaling-Related Proteins in the Spleen of Young Adult RatsFrancisco Javier Pavón, Eva María Marco, Mariam Vázquez, et al.British Journal of Pharmacology|September 29, 2011
Anti-obesity efficacy of LH-21, a cannabinoid CB(1) receptor antagonist with poor brain penetration, in diet-induced obese ratsMónica Alonso, Antonia Serrano, Margarita Vida, et al.Plos One|November 7, 2017
Decreased plasma concentrations of BDNF and IGF-1 in abstinent patients with alcohol use disordersNuria García-Marchena, Daniel Silva-Peña, Ana Isabel Martín-Velasco, et al.Addiction Biology|May 24, 2016
Plasma concentrations of oleoylethanolamide and other acylethanolamides are altered in alcohol-dependent patients: effect of length of abstinenceNuria Garcia-Marchena, Francisco J Pavon, Antoni Pastor, et al.Addiction Biology|June 4, 2015
Role of the satiety factor oleoylethanolamide in alcoholismAinhoa Bilbao, Antonia Serrano, Andrea Cippitelli, et al.Pageof 18